1. Home
  2. HAIN vs VERU Comparison

HAIN vs VERU Comparison

Compare HAIN & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hain Celestial Group Inc. (The)

HAIN

Hain Celestial Group Inc. (The)

HOLD

Current Price

$0.56

Market Cap

53.7M

ML Signal

HOLD

Logo Veru Inc.

VERU

Veru Inc.

N/A

Current Price

$2.63

Market Cap

48.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HAIN
VERU
Founded
1993
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.7M
48.2M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
HAIN
VERU
Price
$0.56
$2.63
Analyst Decision
Hold
Strong Buy
Analyst Count
9
2
Target Price
$2.23
$22.50
AVG Volume (30 Days)
693.2K
278.7K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,457,769,000.00
$16,296,958.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$2.05
52 Week High
$1.95
$7.33

Technical Indicators

Market Signals
Indicator
HAIN
VERU
Relative Strength Index (RSI) 51.68 54.95
Support Level $0.54 $2.12
Resistance Level $0.64 $2.67
Average True Range (ATR) 0.05 0.14
MACD 0.01 0.06
Stochastic Oscillator 60.79 65.75

Price Performance

Historical Comparison
HAIN
VERU

About HAIN Hain Celestial Group Inc. (The)

The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Share on Social Networks: